Certified stroke centers more likely to use tPA, data show

03/28/2013 | MedPage Today (free registration)

Data from the Nationwide Inpatient Sample show more stroke patients treated at certified primary stroke centers got intravenous recombinant tissue plasminogen activator therapy compared with patients treated at other hospitals, University of Pennsylvania researchers reported in the Journal of the American Heart Association. Use of tPA increased at both certified and noncertified centers during the study period, however, researchers said.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA